Balancing Promise And Risk: White House Funds Ibogaine Studies For Veteran PTSD
The White House is funding ibogaine studies for veteran PTSD as regulatory guidance becomes more flexible.
Make this feed yours. Start from this topic, change the words, see it right away. No sign-up.
Make this my feedThe White House is funding ibogaine studies for veteran PTSD as regulatory guidance becomes more flexible.
The American Society of Addiction Medicine released its first national guidance on managing medetomidine withdrawal.
HHS plans to fund up to $4.9 million in research into ibogaine as a treatment for PTSD.
A type 1 diabetes breakthrough is reported to offer hope for children in Western Australia.
Nigeria ended its 21-day Ebola contact monitoring with none of the 62 identified contacts developing the disease.

A look at how a 2014 Johns Hopkins study linking caffeine to memory improvement fared when other labs attempted to replicate it.
A study of more than 750,000 pregnancies found outcomes after early exposure to Ozempic and Wegovy.
An opinion piece argues new organ donation rules may be unfair to families and blur physician roles.
A major study of nearly 1,900 older adults suggests stopping statins after age 70 may be safer than expected, with caveats.

A guide outlines early heatstroke warning signs for parents, noting Ontario has no daycare maximum-temperature rule.
Kratom and 7-OH products are described as feeling miraculous to users while also being addictive.
An article arguing that health encompasses daily habits, emotional environment, sleep, and stress, not just the absence of illness.
A personal essay describes what it is like to learn one may develop Alzheimer's disease and how that changes priorities.
Oura announced it agreed to acquire medical AI chatbot startup Counsel Health in its quarterly earnings.
The article explains how sinus infections can cause upper back tooth pain and how to tell the difference.

The article reviews how AI tools are being used to provide mental health support alongside professional care.
An article discusses how wearable devices are moving beyond fitness tracking toward personalised health insights.

An overview of melanoma as a serious skin cancer, covering its symptoms and treatment options.

A 2025 study examined how prolonged exposure to 3.5 GHz and 24 GHz radiation may affect testicular health and sperm function.
Charlotte Hawkins describes VILPA, a short-burst everyday fitness habit linked to longevity.
A study finds BMI misclassifies obesity for many adults, while a newer method adding waist measurements and organ checks better identifies harmful body fat.

The piece asks whether people can trust AI systems in healthcare to catch what doctors might miss.
Discusses affordability of quality healthcare and access to medical services in India.

An article examining virtual reality as a therapeutic tool in healthcare, including a stroke rehabilitation trial.

The article argues that healthcare AI needs traceable evidence behind its outputs rather than more data.
A wearable UV tracker prompts a look at how sunlight exposure affects health.
An article describing the health benefits of morning walking as a simple daily habit.
The article describes how renewed fighting has pushed Ethiopia's healthcare system close to collapse.
Neuroscience research explores brain-computer interfaces that could help paralyzed people speak again.
A 63-year-old woman describes maintaining a three-stone weight loss through walking and cycling.
Scientists report an experimental treatment that promotes regeneration of damaged heart muscle after a heart attack in animal studies.
A 46-year-old man describes losing 54 pounds and dropping to 11.6% body fat over six months.
A review of over 350 studies suggests reduced protein intake may slow aging.
Ringo Starr, at 86, describes his longevity diet, daily walking and light weightlifting routine.
Nippon.com reports on iPS cell breakthroughs reshaping drug discovery for rare diseases.
Research and clinical challenges in lowering blood pressure after stroke or in people with diabetes.
Three research reports released in early November examine the evidence problem facing medical AI.
AI is helping Texas A&M researchers identify new disease targets hidden in mitochondria.
Reports that missed newborn vitamin K shots in the US are linked to higher risks of severe bleeding and mortality.
Ionis Pharmaceuticals shares fell sharply after a slow rollout of its triglyceride-lowering drug, erasing over $1 billion in market value.
Alnylam relies heavily on its heart drug Amvuttra for growth, and its sales have faced challenges.
MedZERO is presented as a self-evolving LLM agent framework for open-ended medical reasoning through controlled knowledge accumulation.
Research suggests some people still have heart attacks even when bad cholesterol is brought to healthy levels.
Google Cloud launched Gemini for healthcare, an AI agent that pulls patient records to reduce clinical paperwork.
Reports an engineered T-cell therapy producing a deep response in a teenager with advanced kidney cancer.
Novo Nordisk's anti-inflammatory drug failed, but cardiologists say they will still pursue anti-inflammatory approaches to heart disease.
Researchers link a brain wave pattern associated with Alzheimer's-related proteins to memory loss.
An experimental heart disease medicine that lowers a common risk factor unexpectedly failed in trials.
Cristiano Ronaldo is retiring from international soccer at 41 and the piece covers the longevity practices he credits.
Researchers in Nottingham developed a wrist device that appears to help reduce tics in people with Tourette syndrome.
Describe what you care about in plain English. MyFeed scans more than 200 RSS sources and news outlets and delivers only what matters to you.
Ideas to start from